Navigation Links
Thoratec Announces Presentations at Upcoming Investor Conferences
Date:3/3/2011

PLEASANTON, Calif., March 3, 2011 /PRNewswire/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.

On Monday, March 7, the company will participate in the Raymond James 32nd Annual Institutional Investors Conference. David V. Smith, executive vice president and chief financial officer, will provide an update on the company, beginning at 11 a.m., Eastern Standard Time (8 a.m., Pacific Standard Time). The presentation will be available through the conference web site at http://www.wsw.com/webcast/rj62/thor/, or on the company's web site at http://www.thoratec.com.

On Wednesday, March 16, Thoratec will present at the Barclays Capital 2011 Global Healthcare Conference. The presentation by David V. Smith will begin at 9 a.m., Eastern Daylight Time (6 a.m., Pacific Daylight Time) and can be accessed through the conference web site at http://cc.talkpoint.com/barc002/031511a_rb/?entity=92_QCE2BWS, or on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 15,000 devices implanted in patients suffering from heart failure. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web site at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
7. Thoratec Presentation at Canaccord Adams Conference to be Webcast
8. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
9. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
10. Thoratec Presentation at Piper Jaffray Conference to be Webcast
11. Thoratec Presentation at Raymond James Conference to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2017)... the nutrition division of Diplomat Specialty Infusion Group, is celebrating a decade ... To celebrate its anniversary, ThriveRx recently launched a redesigned website at ... improved organization to create the best user experience for consumers and health ... Diplomat ... "We,ve made several great strides throughout the past ...
(Date:7/1/2017)... 30, 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... conference call will be broadcast live over the Internet on ... news release detailing the quarterly results will be made available ... call. The live audio webcast can be accessed ... It will be archived for replay following the conference call. ...
(Date:6/27/2017)... 2017   NuEyes (NuEyes Technologies Inc.) today announced ... its growth in helping the legally blind live more independent ... the leading developer of augmented, virtual and mixed reality smartglasses ... The undisclosed funding amount was provided by strategic partners as ... offices in Abu Dhabi , ...
Breaking Medicine Technology:
(Date:7/18/2017)... Sherman Oaks, CA (PRWEB) , ... July 18, 2017 , ... ... and Ph.D. scientist extracted cannabis oils, announced today that at the WORLDZ Summit, taking ... Ryan will be speaking on the therapeutic benefits of medical cannabis for both pediatric ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... a lien basis, partners with the best medical professionals who offer the most ... pre-approves each medical professional in their network, ensuring that each patient receives prompt ...
(Date:7/18/2017)... Texas (PRWEB) , ... July 19, 2017 , ... ... Gold Winner for it’s Corporate Social Responsibility Initiative in the prestigious CEO World ... in leadership, innovation, organizational performance, new products and services, CEO case studies, corporate ...
(Date:7/17/2017)... ... 2017 , ... McGraw Family Pledges $3 Million for New Learning Center at ... Clinicians , NORWALK, Connecticut – July 17, 2017 – The McGraw family, founders ... health by pledging up to $3 million in a challenge gift to establish the ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... Work For” by the Chronicle of Higher Education for the sixth consecutive year, ... which has campuses in Pomona, California and Lebanon, Oregon, was recognized in seven ...
Breaking Medicine News(10 mins):